EUVIMEDEUVIMED entdecken
Leserbrief

Effectiveness and safety of upadacitinib for moderate‐to‐severe atopic dermatitis in a real‐world setting: A 52‐week retrospective study

L Gargiulo iD, L Ibba iD, F Piscazzi, A Alfano, R Cascio Ingurgio, M Valenti, A Costanzo iD, A Narcisi

Journal of the European Academy of Dermatology and Venereology · 2024

DOI: 10.1111/jdv.19507 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, 2024. Verfasst von L Gargiulo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology Unit, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy. Hauptthemen laut MEDLINE: Dermatitis, Atopic. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, AtopicHumansRetrospective StudiesHeterocyclic Compounds, 3-RingTreatment OutcomeSeverity of Illness IndexDouble-Blind Method

Substanzen

upadacitinibHeterocyclic Compounds, 3-Ring

Autor:innen und Institutionen

  • Dermatology Unit, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.
  • Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.

ORCID-Profile: L Gargiulo, L Ibba, A Costanzo

Zitieren

APA

Gargiulo, L., Ibba, L., Piscazzi, F., Alfano, A., Cascio Ingurgio, R., Valenti, M., Costanzo, A., & Narcisi, A. (2024). Effectiveness and safety of upadacitinib for moderate‐to‐severe atopic dermatitis in a real‐world setting: A 52‐week retrospective study. Journal of the European Academy of Dermatology and Venereology. https://doi.org/10.1111/jdv.19507

Vancouver

Gargiulo L, Ibba L, Piscazzi F, Alfano A, Cascio Ingurgio R, Valenti M, et al. Effectiveness and safety of upadacitinib for moderate‐to‐severe atopic dermatitis in a real‐world setting: A 52‐week retrospective study. Journal of the European Academy of Dermatology and Venereology. 2024. doi:10.1111/jdv.19507

BibTeX
@article{Gargiulo2024,
  author = {Gargiulo, L and Ibba, L and Piscazzi, F and Alfano, A and Cascio Ingurgio, R and Valenti, M and Costanzo, A and Narcisi, A},
  title = {Effectiveness and safety of upadacitinib for moderate‐to‐severe atopic dermatitis in a real‐world setting: A 52‐week retrospective study},
  journal = {Journal of the European Academy of Dermatology and Venereology},
  year = {2024},
  doi = {10.1111/jdv.19507}
}
Kostenlos starten →